Cargando…

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study

BACKGROUND: The gut-brain axis is a bidirectional signaling pathway between the gastrointestinal tract and the brain; it is being studied because of its potential influence in mediating mood, anxiety, and other neuropsychiatric symptoms. Previous research examining the effects of gut microbiota on n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinna Meyyappan, Arthi, Sgarbossa, Cassandra, Vazquez, Gustavo, Bond, David J, Müller, Daniel J, Milev, Roumen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495575/ https://www.ncbi.nlm.nih.gov/pubmed/34550085 http://dx.doi.org/10.2196/31439

Ejemplares similares

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020)

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2022)

Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
por: Forth, Evan, et al.
Publicado: (2023)

Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020)

Probiotics as Adjuvant Treatment for Psychiatric Disorders: A Systematic Review
por: Forth, E. A., et al.
Publicado: (2023)

Sleep architecture and cognitive changes in olanzapine-treated patients with depression: A double blind randomized placebo controlled trial
por: Lazowski, Lauren K, et al.
Publicado: (2014)

Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
por: Gilron, Ian, et al.
Publicado: (2017)

Melatonin for Neuropathic Pain: Protocol for a Double-blind, Randomized Controlled Trial
por: Gilron, Ian, et al.
Publicado: (2022)

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain
por: Gilron, Ian, et al.
Publicado: (2017)

Effects, experiences, and impact of stigma on patients with bipolar disorder
por: Mileva, Viktoria R, et al.
Publicado: (2013)

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
por: Baskaran, Anusha, et al.
Publicado: (2013)

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015)

Combining Ketamine and Internet-Based Cognitive Behavioral Therapy for the Treatment of Posttraumatic Stress Disorder: Protocol for a Randomized Controlled Trial
por: Philipp-Muller, Aaron Emile, et al.
Publicado: (2021)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
por: Vieta, Eduard, et al.
Publicado: (2019)

OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females
por: Brin, Mitchell F., et al.
Publicado: (2020)

Delay effects on the stability of large ecosystems
por: Pigani, Emanuele, et al.
Publicado: (2022)

Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
por: Cavanna, Federico, et al.
Publicado: (2022)

Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
por: Segal, Leopoldo N, et al.
Publicado: (2017)

A double-blind placebo needle for acupuncture research
por: Takakura, Nobuari, et al.
Publicado: (2007)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
por: Durgam, Suresh, et al.
Publicado: (2018)

Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder
por: Wood-Ross, Chelsea, et al.
Publicado: (2022)

A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder
por: Papakostas, G. I., et al.
Publicado: (2019)

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
por: Montgomery, Stuart A., et al.
Publicado: (2014)

Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression
por: Laferton, Johannes A. C., et al.
Publicado: (2018)

Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
por: Durgam, Suresh, et al.
Publicado: (2018)

Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
por: Fava, Maurizio, et al.
Publicado: (2018)

Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder
por: Inoue, Takeshi, et al.
Publicado: (2019)

Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2021)

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
por: Walter, Maggie C, et al.
Publicado: (2013)

Olfactory Functioning and Depression: A Systematic Review
por: Taalman, Hannah, et al.
Publicado: (2017)

Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

In a secondary analysis from a randomised, double-blind placebo-controlled trial Dexmedetomidine blocks cholinergic dysregulation in delirium pathogenesis in patients with major surgery
por: Jacob, Yanite, et al.
Publicado: (2023)

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2012)

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
por: Dean, Olivia May, et al.
Publicado: (2014)

Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
por: Mathews, Maju, et al.
Publicado: (2015)

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
por: Han, Yu, et al.
Publicado: (2016)

Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study
por: Durgam, Suresh, et al.
Publicado: (2019)

A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder
por: Attwells, Sophia, et al.
Publicado: (2021)

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
por: von Rotz, Robin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pd7bv6duoq99dputjo0ug8h3iv